A detailed history of Brown Brothers Harriman & CO transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 540,368 shares of TMO stock, worth $293 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
540,368
Previous 545,094 0.87%
Holding current value
$293 Million
Previous $301 Million 10.88%
% of portfolio
2.38%
Previous 2.37%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$531.86 - $624.21 $2.51 Million - $2.95 Million
-4,726 Reduced 0.87%
540,368 $334 Million
Q2 2024

Aug 09, 2024

SELL
$541.52 - $599.02 $4.48 Million - $4.95 Million
-8,264 Reduced 1.49%
545,094 $301 Million
Q1 2024

May 10, 2024

SELL
$528.82 - $599.43 $3.15 Million - $3.57 Million
-5,948 Reduced 1.06%
553,358 $322 Million
Q4 2023

Feb 12, 2024

SELL
$431.41 - $532.94 $5.92 Million - $7.32 Million
-13,728 Reduced 2.4%
559,306 $297 Million
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $4.68 Million - $5.4 Million
-9,401 Reduced 1.61%
573,034 $290 Million
Q2 2023

Aug 07, 2023

BUY
$508.46 - $591.13 $12.6 Million - $14.6 Million
24,733 Added 4.43%
582,435 $304 Million
Q1 2023

May 11, 2023

SELL
$535.0 - $604.82 $6.05 Million - $6.84 Million
-11,301 Reduced 1.99%
557,702 $321 Million
Q4 2022

Feb 09, 2023

SELL
$484.71 - $571.37 $5.74 Million - $6.77 Million
-11,846 Reduced 2.04%
569,003 $313 Million
Q3 2022

Nov 10, 2022

BUY
$507.19 - $604.49 $6.4 Million - $7.63 Million
12,614 Added 2.22%
580,849 $295 Million
Q2 2022

Aug 11, 2022

BUY
$500.9 - $612.21 $15.9 Million - $19.4 Million
31,737 Added 5.92%
568,235 $309 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $5.52 Million - $6.79 Million
10,530 Added 2.0%
536,498 $317 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $2.47 Million - $2.9 Million
-4,345 Reduced 0.82%
525,968 $351 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $5.8 Million - $6.94 Million
-11,384 Reduced 2.1%
530,313 $303 Million
Q2 2021

Aug 13, 2021

SELL
$441.0 - $508.24 $212,562 - $244,971
-482 Reduced 0.09%
541,697 $273 Million
Q1 2021

May 13, 2021

BUY
$439.85 - $518.83 $36.5 Million - $43.1 Million
82,981 Added 18.07%
542,179 $247 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $3.12 Million - $3.79 Million
-7,182 Reduced 1.54%
459,198 $214 Million
Q3 2020

Nov 16, 2020

BUY
$359.77 - $441.52 $165 Million - $202 Million
457,783 Added 5324.92%
466,380 $206 Million
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $62,470 - $82,251
227 Added 2.71%
8,597 $3.12 Million
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $127,905 - $170,365
-501 Reduced 5.65%
8,370 $2.37 Million
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $45,140 - $54,454
-166 Reduced 1.84%
8,871 $2.88 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $24,966 - $28,404
93 Added 1.04%
9,037 $2.63 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $28,068 - $32,214
109 Added 1.23%
8,944 $2.63 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $472,714 - $609,848
2,228 Added 33.72%
8,835 $2.42 Million
Q4 2018

Feb 14, 2019

SELL
$208.47 - $251.98 $120,287 - $145,392
-577 Reduced 8.03%
6,607 $1.48 Million
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $114,091 - $135,597
-555 Reduced 7.17%
7,184 $1.75 Million
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $58,098 - $62,785
-286 Reduced 3.56%
7,739 $1.6 Million
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $230,611 - $267,811
-1,195 Reduced 12.96%
8,025 $1.66 Million
Q4 2017

Feb 14, 2018

SELL
$182.03 - $200.37 $107,033 - $117,817
-588 Reduced 6.0%
9,220 $1.75 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $39,328 - $44,435
-229 Reduced 2.28%
9,808 $1.86 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,037
10,037 $1.75 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $212B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.